Diagnostic Reagent Facility, ICMR-National Institute of Virology, Pune, Maharashtra, India.
Bioinformatics and Data Management Group, ICMR-National Institute of Virology, Pune, Maharashtra, India.
Rev Med Virol. 2023 Sep;33(5):e2468. doi: 10.1002/rmv.2468. Epub 2023 Jun 22.
Serum ferritin levels serves as biomarkers in many inflammatory and infectious diseases. This current systematic review and meta-analysis evaluated whether serum ferritin levels are associated with severe dengue and its utility as a biomarker of disease severity. Literature searches were conducted in PubMed, Scopus, ScienceDirect, the Cochrane library, and Google Scholar. A total of 18 studies examining the serum ferritin levels in dengue cases in the context of disease severity (nine studies having dengue classification as non-severe vs. severe dengue cases, and nine studies having dengue classification as dengue without warning signs (DwoWS), dengue with warning signs (DwWS), and severe dengue cases) were included and the quality of the studies was assessed using the Quality in Prognostic Factor Studies tool. The meta-analysis was performed using STATA software to calculate the effect size as a standardized mean difference (SMD) or Hedges 'g' for the continuous outcome. Higher serum ferritin levels were found in severe dengue cases compared to non-severe cases [SMD (Hedges 'g') 4.05 (95% C.I. 2.09-6.00), (I = 98.8%)]. In the second group, DwWS cases showed high serum ferritin levels compared to DwoWS [SMD 2.01 (95% C.I. 0.92-3.10), (I = 97.89%)], and severe dengue cases showed higher levels of serum ferritin compared to DwWS [SMD 2.66 (95% C.I. 1.72-4.48), (I = 98.78%)] and DwoWS cases [SMD 6.65 (95% C.I. 1.72-11.59), (I = 99.78%]. Subgroup analysis for the country of study (India vs. others), ferritin testing methods, and ferritin measurement day revealed testing method as a significant contributor to heterogeneity. To conclude, the present study suggests serum ferritin as a prognostic marker for dengue disease severity. Multi-centric studies involving a large number of dengue patients with a uniform case definition accounting for all the confounding variables might help in determining a universal cut-off value to discriminate between non-severe and severe dengue.
血清铁蛋白水平可作为许多炎症和感染性疾病的生物标志物。本系统评价和荟萃分析评估了血清铁蛋白水平是否与重症登革热相关,以及其作为疾病严重程度的生物标志物的作用。文献检索在 PubMed、Scopus、ScienceDirect、Cochrane 图书馆和 Google Scholar 中进行。共纳入 18 项研究,这些研究在疾病严重程度背景下检查了登革热病例的血清铁蛋白水平(9 项研究将登革热分类为非重症与重症登革热病例,9 项研究将登革热分类为无预警症状登革热(DwoWS)、有预警症状登革热(DwWS)和重症登革热病例),并使用预后因素研究质量工具评估了研究的质量。使用 STATA 软件进行荟萃分析,以计算标准化均数差(SMD)或 Hedge 'g'作为连续结局的效应量。与非重症病例相比,重症登革热病例的血清铁蛋白水平更高[SMD(Hedge 'g')4.05(95%置信区间 2.09-6.00),(I=98.8%)]。在第二组中,DwWS 病例的血清铁蛋白水平高于 DwoWS[SMD 2.01(95%置信区间 0.92-3.10),(I=97.89%)],重症登革热病例的血清铁蛋白水平高于 DwWS[SMD 2.66(95%置信区间 1.72-4.48),(I=98.78%)]和 DwoWS 病例[SMD 6.65(95%置信区间 1.72-11.59),(I=99.78%)]。按研究国家(印度与其他国家)、铁蛋白检测方法和铁蛋白测量日进行的亚组分析显示,检测方法是异质性的重要来源。总之,本研究提示血清铁蛋白可作为登革热疾病严重程度的预后标志物。涉及大量登革热患者、具有统一病例定义并考虑所有混杂变量的多中心研究可能有助于确定区分非重症和重症登革热的通用截止值。